Stay updated on Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Sign up to get notified when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Removed related topics 'Multiple Myeloma' and 'MedlinePlus Genetics' from the page's related topics.
    Difference
    0.1%
    Check dated 2026-02-21T10:18:58.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    New topic tags 'Multiple myeloma' and a related topic 'MedlinePlus Genetics' were added, and the page revision updated from v3.4.1 to v3.4.2. These changes are metadata-level and do not alter the study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T05:53:21.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.4.1 is now shown, replacing v3.4.0, indicating a minor update to the study documentation/version. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-07T04:44:57.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    Multiple myeloma and MedlinePlus Genetics related topics were removed from the page's topics/keywords. This changes how the study is categorized and found by users researching the condition.
    Difference
    0.1%
    Check dated 2026-01-31T01:45:20.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a Show glossary option and new metadata fields: Last Update Submitted that Met QC Criteria and Last Update Posted, along with a site revision note 'Revision: v3.4.0'. Removed older labels: Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, and the previous Revision: v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-23T22:23:57.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Added related topics: Multiple Myeloma and MedlinePlus Genetics, and updated page revision to v3.3.4 (from v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T01:24:02.000Z thumbnail image

Stay in the know with updates to Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo vs Lenalidomide/Dex in Untreated Myeloma Clinical Trial page.